FMC Corp vs Moody's Corporation — how do they compare? FMC Corp trades at $11.17 (market cap $1.36B), while Moody's Corporation trades at $509.93 (market cap $88.12B). The key difference: Moody's Corporation is far larger — about 64.8× FMC Corp's market cap, and FMC Corp pays the higher dividend (2.95%). Which is the better fit depends on your goals.
| FMC | MCO | |
|---|---|---|
Market Cap | $1.36B | $88.12B |
Sector | Basic Materials | Financials |
52-Week High | $43.90 | $539.61 |
52-Week Low | $10.72 | $412.23 |
Enterprise Value | $5.50B | $93.92B |
Dividend Yield | 2.95% | 0.82% |
Signals from Pluang's Aura AI — not financial advice
FMC Corporation (FMC) trades at $10.72, down 1.74% on the day, reflecting ongoing challenges despite recent strategic moves. The stock shows a bearish technical trend with oversold RSI signals, while fundamentals reveal significant pressure with a net income margin of -72.93% and negative ROE of -80.78% for 2025. Recent developments include a $400 million minority investment from Tessenderlo Group and regulatory submission for new herbicide rimisoxafen, providing some operational support amid financial restructuring.
The outlook remains cautious with analyst consensus leaning neutral (50% Hold) despite a $16 price target suggesting 49% upside. Key risks include persistent revenue declines, high debt levels, and negative cash flow from operations. Investment opportunity exists if new product approvals and debt reduction efforts successfully stabilize profitability, but current financial metrics indicate substantial execution risk near term.
Moody's Corporation (MCO) trades at $494.73, down 0.2% on the day, with a bullish technical signal from moving averages. The company demonstrates strong fundamentals with revenue growth to $7.72B in 2025 and a robust net income margin of 31.69%. Recent earnings have consistently beaten expectations, and analyst consensus remains positive with a $539.40 price target. The stock is supported by Moody's dominant position in credit ratings and strategic AI integration initiatives.
Outlook remains favorable given Moody's oligopoly position, recurring revenue model, and 17-year dividend growth streak. Key opportunities include leveraging AI capabilities and benefiting from corporate debt issuance cycles. Risks include valuation concerns with a P/E of 36.19, regulatory scrutiny of credit rating agencies, and potential economic slowdowns affecting debt markets.
Trailing returns across standard periods
Latest headlines on both assets
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →Moody's, along with S&P Ratings, is a leading provider of credit ratings on fixed income securities. Moody's ratings segment, known as Moody's Investors Service or MIS, includes corporates, structured finance, financial institutions, and public finance ratings. MIS represents a majority of the firm's revenue and profits. Moody's other segment is Moody's Analytics and consists of Research, Data, and Analytics or RD&A and Enterprise Risk Solutions or ERS. RD&A's products include credit research, quantitative credit scores, economic research, business intelligence, know your customer (KYC) tools, commercial real estate data and analytical tools, and training services. ERS includes risk management software solutions to financial institutions.
Read more on MCO →